2020 BIO International Convention Transitions to Online-Only Conference Due to COVID-19
The digital event, called Bio Digital 2020, will now take place from June 8–12, 2020.
The Biotechnology Innovation Organization (BIO) announced on April 3, 2020 that the 2020 BIO International Convention, originally scheduled for June 8–11, 2020 in San Diego, CA, will now transition to an online-only platform due to the continuing outbreak of COVID-19. The digital event, called Bio Digital 2020, will take place from June 8–12, 2020.
According to a press release, BIO will use its BIO One-on-One Partnering system to give attendees access to schedule virtual meetings and enhance their business development and licensing capabilities via partnerships and virtual collaboration. The online conference will also feature live and on-demand panels focused on COVID-19, infectious diseases, vaccine development, digital health, business development, and the latest therapeutic advancements in biotech.
“The coronavirus is an urgent focus for the biotechnology industry as we work tirelessly to combat this public health threat,” said Jim Greenwood, BIO president and CEO, in the press release. “Now, more than ever, it’s critical for the biotechnology world to convene and forge collaborations, partnerships, and research to advance innovations for our patients and to solve our most timely global issues.”
Source: BIO
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
